435 related articles for article (PubMed ID: 19603590)
1. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
[TBL] [Abstract][Full Text] [Related]
2. Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging.
Sadan O; Shemesh N; Barzilay R; Bahat-Stromza M; Melamed E; Cohen Y; Offen D
Stem Cells; 2008 Oct; 26(10):2542-51. PubMed ID: 18635865
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
Sadan O; Bahat-Stromza M; Barhum Y; Levy YS; Pisnevsky A; Peretz H; Ilan AB; Bulvik S; Shemesh N; Krepel D; Cohen Y; Melamed E; Offen D
Stem Cells Dev; 2009 Oct; 18(8):1179-90. PubMed ID: 19243240
[TBL] [Abstract][Full Text] [Related]
5. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells.
Pineda JR; Rubio N; Akerud P; Urbán N; Badimon L; Arenas E; Alberch J; Blanco J; Canals JM
Gene Ther; 2007 Jan; 14(2):118-28. PubMed ID: 16943855
[TBL] [Abstract][Full Text] [Related]
7. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain.
Moloney TC; Rooney GE; Barry FP; Howard L; Dowd E
Brain Res; 2010 Nov; 1359():33-43. PubMed ID: 20732313
[TBL] [Abstract][Full Text] [Related]
8. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease.
Dey ND; Bombard MC; Roland BP; Davidson S; Lu M; Rossignol J; Sandstrom MI; Skeel RL; Lescaudron L; Dunbar GL
Behav Brain Res; 2010 Dec; 214(2):193-200. PubMed ID: 20493905
[TBL] [Abstract][Full Text] [Related]
11. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
[TBL] [Abstract][Full Text] [Related]
12. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
13. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
14. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
15. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
16. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
[TBL] [Abstract][Full Text] [Related]
17. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.
Jin GZ; Cho SJ; Choi EG; Lee YS; Yu XF; Choi KS; Yee ST; Jeon JT; Kim MO; Kong IK
Cell Biol Int; 2008 Nov; 32(11):1433-8. PubMed ID: 18778785
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia.
Jones J; Jaramillo-Merchán J; Bueno C; Pastor D; Viso-León M; Martínez S
Neurobiol Dis; 2010 Nov; 40(2):415-23. PubMed ID: 20638477
[TBL] [Abstract][Full Text] [Related]
19. [Growth factors as neuroprotective treatment in Parkinson disease?].
Torp R; Singh PB; Sørensen DR; Dietrichs E; Hirschberg H
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):899-901. PubMed ID: 16554879
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]